Johnson & Johnson explores sale/spin of DePuy Synthes unit
Johnson & Johnson is exploring a near-term sale or spin-off of its DePuy Synthes hips and knees unit for about $20B, while advancing several business updates mentioned in the recap.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.